Outcome of patients with anticardiolipin antibodies: A 10 year follow-up of 52 patients

Lupus

Volumn 7, Issue 1, 1998, Pages 3-6

  Shah, N M ^a   Khamashta, M A ^a   Atsumi, T ^a   Hughes, G R V ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Pregnancy loss; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOLIPIN ANTIBODY; DIPYRIDAMOLE; HEPARIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PHENINDIONE; WARFARIN;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; DISCOID LUPUS ERYTHEMATOSUS; DISEASE COURSE; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT MONITORING; PRIORITY JOURNAL; RECURRENT ABORTION; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SEROLOGY; SJOEGREN SYNDROME; SPONTANEOUS ABORTION; SYNDROME CREST; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOSIS; VALVULAR HEART DISEASE; VEIN THROMBOSIS; WEGENER GRANULOMATOSIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED;

EID: 0031962125     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120398678919624     Document Type: Article

References (13)

1. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993; 342: 341-344.
2. Khamashta MA, Hughes GRV. Antiphospholipid antibodies and antiphospholipid syndrome Curr Opin Rheumatol 1995; 7: 389-394.
3. Harris EN, Gharavi AE, Patel BM, Hughes GRV. Evaluation of the anticardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68: 215-222.
4. Harris EN, Pierangeli S, Birch D. Anticardiolipin wet workshop report: Vth International Symposium on Antiphospholipid Antibodies. Am J Clin Pathol 1994; 101: 616-624.
5. Vianna JL et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicentre study of 114 patients. Am J Med 1994; 96: 3-9.
6. Ginsburg KS et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 1992; 117: 997-1002.
7. Petri M et al. The Hopkins lupus cohort: a longitudinal study of predictors of thrombosis. Lupus 1994; 3: 361.
8. Finazzi G et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian registry. Am J Med 1996; 100: 530-536.
9. Perez-Vazquez ME, Villa AR, Drenkard C, Cabiedes J, Alarcon-Segovia D. Influence of disease duration, continued follow-up and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus. J Rheumatol 1993; 29: 437-442.
10. Lockshin MD. Which patients with antiphospholipid antibody should be treated and how? Rheum Dis Clin North Am 1993; 19: 235-247.
11. Drenkard C, Villa AR, Alarcon-Segovia D, Perez-Vazquez ME. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus. J Rheumatol 1994; 21: 1067-1072
12. Gulko PS et al. Anticardiolipin antibodies in systemic lupus erythematosus: clinical correlation, HLA associations and impact on survival. J Rheumatol 1993; 20: 1684-1693.
13. Khamashta MA et al The management of thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 1995; 332: 993-997